| Detected | Trial | Change |
|---|---|---|
| 2026-06-06 | NCT06331312 Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR) |
Trial sites reduced: 99 -> 83 locations |
| 2026-06-06 | NCT06331312 Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR) |
date change Primary completion moved earlier: 2028-08-22 -> 2028-05-08 |
| 2026-06-06 | NCT06331312 Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR) |
date change Completion moved earlier: 2028-08-22 -> 2028-05-08 |
| 2026-06-04 | NCT07489573 Study of Efficacy and Safety of Secukinumab in Chinese Adult Patients With Moderate to… |
Recruitment opened |
| 2026-06-03 | NCT05622708 A Study of Secukinumab to Evaluate Maintenance of Response in Participants With… |
date change Primary completion moved earlier: 2028-04-19 -> 2028-02-08 |
| 2026-06-03 | NCT05622708 A Study of Secukinumab to Evaluate Maintenance of Response in Participants With… |
date change Completion moved earlier: 2028-06-13 -> 2028-04-04 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05303285 | A Study Evaluating the Efficacy of Secukinumab 300mg in Chinese Adults With Active… | Ankylosing Spondylitis (AS) | Recruiting |
| NCT06398106 | Proactive TDM Versus Standard Use of Biologics in Psoriasis | Psoriasis Vulgaris | Recruiting |
| NCT07489573 | Study of Efficacy and Safety of Secukinumab in Chinese Adult Patients With Moderate to… | Hidradenitis Suppurativa (HS) | Recruiting |
| NCT07485764 | Metformin Combined With Secukinumab for Moderate-to-Severe Plaque Psoriasis in Overweight… | Psoriasis | Not Yet Recruiting |
| NCT05622708 | A Study of Secukinumab to Evaluate Maintenance of Response in Participants With… | Non-radiographic Axial Spondyloarthritis | Active, Not Recruiting |
| NCT07352566 | Utilization of a Microdevice for Psoriasis and Atopic Dermatitis | Psoriasis | Not Yet Recruiting |
| Phase 3 | |||
| NCT04179175 | Extension Study to Assess Effects of Non-interrupted Versus Interrupted and Long Term… | Hidradenitis Suppurativa | Active, Not Recruiting |
| NCT06945107 | A Study of Switching to Picankibart in Chinese Patients With Plaque Psoriasis With an… | Plaque Psoriasis | Active, Not Recruiting |
| NCT06331312 | Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR) | Polymyalgia Rheumatica | Active, Not Recruiting |
| Phase 2 | |||
| NCT07477795 | Phase II Interventional Study Evaluating Efficacy and Safety of Secukinumab in Active… | Takayasu Arteritis | Not Yet Recruiting |
| Phase 1 | |||
| NCT06751238 | Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of… | Juvenile Psoriatic Arthritis | Recruiting |
| NCT07254325 | Pharmacokinetic, Safety and Immunogenicity Study of New Process CMAB015 and Cosentyx in… | Psoriasis | Active, Not Recruiting |
| Not specified | |||
| NCT06905288 | Real-world Study on Secukinumab Effectiveness in Biologic-naïve Ankylosing Spondylitis… | Ankylosing Spondylitis | Recruiting |
| NCT07243782 | Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque… | Hidradenitis Suppurativa | Recruiting |